<DOC>
	<DOCNO>NCT00002065</DOCNO>
	<brief_summary>To assess safety efficacy depot disulfiram new treatment AIDS AIDS relate complex .</brief_summary>
	<brief_title>Depot Disulfiram AIDS ARC</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Disulfiram</mesh_term>
	<criteria>Inclusion Criteria Patients must positive diagnosis AIDS AIDS relate complex ( ARC ) accord CDC criterion . Also patient must : Able understand study . Strongly motivated participate study , willing comply condition specify informed consent form . Ambulatory able maintain independent life outside hospital . Free clinically significant organic disease affect neurologic , hepatic , renal , clinical status . Patients must free clinically significant organic disease affect neurologic , hepatic , renal , clinical status . Patients must free clinically significant organic disease affect neurologic , hepatic , renal , clinical status . History alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 1999</verification_date>
	<keyword>Delayed-Action Preparations</keyword>
	<keyword>Disulfiram</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>